BVF Partners OS, Director: MoonLake Immunotherapeutics MLTX Sell · Filed 04/02

Trade details

Type: Insider sale
Amount: $32,444,223.66
Shares · price: 1,932,354 sh · $16.79 a share
Held after: 8,302,735 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: BVF Partners OSDirector
Trade date: 26/03/31
Filed: 26/04/02
Days to filing: 2 days

Sold 18.9% of holdings

Share of holding sold: 18.9%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

BVF Partners OS's recent trades

BVF Partners OSDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
BVF Partners OSDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF Partners OSDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF Partners OSDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF Partners OSDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$26.3M
1,569,116 sh
$26.3M
Filed 04/02
Traded 03/31

BVF Partners OS, Director — sold $32.4M of MoonLake Immunotherapeutics MLTX · 18.9% of holdings | Whalegun